Perspectum announced that completed the first close of its Series C funding round, bringing in a new $36 million investment. Oppenheimer Holdings led the funding round. The Series C brings Perspectum’s total amount raised since inception to about $120 million. “We are excited to have Oppenheimer and British Patient Capital join our mission to create […]
Perspectum Diagnostics
Perspectum wins FDA nod for biliary duct mapping software
Perspectum Diagnostics said this week that it won 510(k) clearance from the FDA for its biliary visualization software, MRCP+. The company’s AI-powered software is designed to provide improved visualization, monitoring and reporting of intra-hepatic ducts. The metrics produced by MRCP+ could be particularly useful for doctors monitoring patients with primary sclerosing cholangitis, according to Perspectum […]
Perspectum Diagnostics wins FDA 510(k) for LiverMultiscan MR device
Perspectum Diagnostics said it won FDA 510(k) clearance for its LiverMultiscan MR imaging device designed to detect early liver disease. The LiverMultiScan uses quantitative MR methods and provides a highly detailed map of the whole liver for clinicians to identify regions of disease, the U.K.-based company said. Perspectum Diagnostics said the device is currently used […]